HealthAbbVie Reports 40.5% Crohn’s Remission With ABBV-466 at Week 24By Naomi CalderOct 19, 2026, 2:04 PM UTC
HealthAbbVie Reports 86.6% Crohn’s Remission at Week 144 in IBD StudyBy Naomi CalderOct 17, 2026, 10:14 AM UTC